The Site PI (Dr. Khan) and associates will conduct the study as per KUMC Protocol STUDY00146320 [version 1.1a, 5- 28-2021; and any future amendments to that protocol], Randomized IIB Study of the Effect of Bazedoxifene plus Conjugated Estrogens on Breast Imaging and Tissue Biomarkers in Peri or Post-Menopausal Women at Increased Risk for Development of Breast Cancer.
|Effective start/end date||2/1/22 → 1/31/26|
- University of Kansas Medical Center Research Institute, Inc. (GR16843//5R01CA249437-02)
- National Cancer Institute (GR16843//5R01CA249437-02)
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.